-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
GoodRx Holdings, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2019 to Q2 2024.
- GoodRx Holdings, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $93.5M, a 20.7% increase year-over-year.
- GoodRx Holdings, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $369M, a 13% increase year-over-year.
- GoodRx Holdings, Inc. annual Selling and Marketing Expense for 2023 was $341M, a 4.56% decline from 2022.
- GoodRx Holdings, Inc. annual Selling and Marketing Expense for 2022 was $358M, a 3.4% decline from 2021.
- GoodRx Holdings, Inc. annual Selling and Marketing Expense for 2021 was $370M, a 45.1% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)